A global framework for artificial intelligence education in medicine: international working group recommendations

By: Laura C. Rosella · Yindalon Aphinyanaphongs · James Barry · Orest Boyko · Harvey Castro · Anthony Chang · Shane Eaton · Bradley J. Erickson · Jamie Fairclough · Diana Ferro · Gregg Gascon · Nihal Haque · Robert Hoyt · Johanna Kim · Alfonso Limon · Pietro Lio · Muhammad Mamdani · Piyush Mathur · Ryan McAdams · Ehsan Misaghi · Abhishek Moturu · Hari Mudipalli · Arwa Nada · Oded Nov · Mijanou Pham · Gemma Postill · Zoryana Salo · Marianne So · Ying Wan · Nathan Yung

9 September 2026 at 08:00

npj Digital Medicine, Published online: 09 September 2026; doi:10.1038/s41746-026-03197-x

Disruption of the AR/ZNF217/PROM2 axis sensitizes prostate cancer to ferroptosis and enzalutamide therapy

Oncogenesis - nature.com science feeds

By: Wenjun Hao · Peng Liang · Wanglong Zheng · Minglu Sheng · Yulin Peng · Xiang Gao · Haolin Zhao · Yuyan Zhu · Yanlong Wang · Bo Fan · Zhihong Dai · Xu Sun · Liang Wang · Huan Qi · Ying Wang · Yan Wang · Zhenlong Yu · Zhiyu Liu

11 August 2026 at 08:00

Oncogenesis, Published online: 11 August 2026; doi:10.1038/s41389-026-00649-7

Disruption of the AR/ZNF217/PROM2 axis sensitizes prostate cancer to ferroptosis and enzalutamide therapy

In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study

Nature Medicine

By: Ning An · Di Wang · Peiling Zhang · Jishuai Zhang · Philippe Parone · Jianlin Hu · Yuhan Bao · Li Xu · Haitao Ruan · Ying Wan · Xinyu Wen · Yang Gao · Chunrui Li

25 March 2026 at 08:00

Nature Medicine, Published online: 25 March 2026; doi:10.1038/s41591-026-04244-6

In a phase 1 trial, the in vivo generation of anti-BCMA CAR-T cells by lentiviral delivery was feasible and did not lead to dose-limiting toxicities in five patients with relapsed or refractory multiple myeloma.

Reading view